LONG WuxiBiologicsWuXi Biologics outstanding CRDMO in biotech sector is preparing for a bullrun. Beside the Biosecure Act of US. The stock looks attractive.
Prepare for corrective move to the upside.
Long
Wuxi Biologics (Cayman) Inc
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.14 USD
468.23 M USD
2.61 B USD
3.75 B
About Wuxi Biologics (Cayman) Inc.
Sector
Industry
CEO
Zhi Sheng Chen
Website
Headquarters
Wuxi
Founded
2014
IPO date
Jun 13, 2017
Identifiers
3
ISIN KYG970081173
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.
Related stocks
Long
Wuxi Biologics (2269): Incredible long-term opportunity! Wuxi Biologics (2269): HKEX:2269
Wuxi Biologics, a Chinese biotech research company listed on the Hong Kong Stock Exchange, presents a complex investment scenario. It's crucial to note we're dealing with the Hong Kong Dollar, not the US dollar. The comprehensive analysis on the weekly chart sug
Long
2269.HK is going to fly ~ (1st target: 77.8, 2nd target: 90.05)2269.HK has experienced a long decline for more than 1 year due to local and oversea government policies, although its P&L has growth a lot. 2269.HK is going to complete a head and shoulder pattern within the last 70 days, and highly likely to fly in the near term. The first target will be 77.8 and
Long
Long
WUXI Biologics dropped by 5%, good time to add! WUXI Biologics dropped by 5%, forming a bullish M pattern! Good time to add since nothing changed in fundamentals and this is a selloff by the Capital Group probably due to profit taking.
Short
Price broke below the trendline, could be a fakeout! Price broke below the trendline, could be a fakeout! Fundamentals are still strong for equity market, not worrying about crash, but think it could be a good pullback to add some positions here !
Long
2269HKEX:2269
Fast Turtle Buy
FiFT +VE Recharge
MCDX+ Spike Up +ve
Banker 90%
Atom is on highway
Resistance turn support
SL Below 105
Want subscribe Turtle Trading System pls PM ME
Long
WUXI BIOLOGICS - Chinese Drug Developer - Nice PullbackWUXI traded on the Hong Kong Exchange as 2269 has had a great run over the last 12 months, up some 210% post March 2020.
Nice big pullback to a value / support area. Could be worth a look if it heads back up.
One Year View
Long
Long
Wuxi Biologics Cayman Inc (2269 - HK) - 5th wave upWuxi Biologics Cayman Inc (2269 - HK) is in 5th wave up of major 5th wave of C wave up in daily time frame. It is now in 5th wave up after sharp 4th wave ended just above wave 1 territory. It also be possible that extension is on the way. But conservatively it is now in 5th wave progress with small
Long
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
513120
GF CSI Hong Kong Brand Name Drug Exchange Traded Fund UnitsWeight
9.57%
Market value
181.56 M
USD
3432
CSOP ETF Series - CSOP MSCI HK China Connect Select ETF UnitsWeight
5.89%
Market value
90.74 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of WXIBF is 5.20 USD — it hasn't changed in the past 24 hours. Watch Wuxi Biologics (Cayman) Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Wuxi Biologics (Cayman) Inc stocks are traded under the ticker WXIBF.
WXIBF stock has risen by 21.54% compared to the previous week, the month change is a 23.22% rise, over the last year Wuxi Biologics (Cayman) Inc has showed a 112.24% increase.
We've gathered analysts' opinions on Wuxi Biologics (Cayman) Inc future price: according to them, WXIBF price has a max estimate of 6.98 USD and a min estimate of 4.74 USD. Watch WXIBF chart and read a more detailed Wuxi Biologics (Cayman) Inc stock forecast: see what analysts think of Wuxi Biologics (Cayman) Inc and suggest that you do with its stocks.
WXIBF reached its all-time high on Nov 16, 2020 with the price of 34.25 USD, and its all-time low was 1.30 USD and was reached on Aug 22, 2024. View more price dynamics on WXIBF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
WXIBF stock is 0.00% volatile and has beta coefficient of 1.48. Track Wuxi Biologics (Cayman) Inc stock price on the chart and check out the list of the most volatile stocks — is Wuxi Biologics (Cayman) Inc there?
Today Wuxi Biologics (Cayman) Inc has the market capitalization of 21.88 B, it has increased by 3.37% over the last week.
Yes, you can track Wuxi Biologics (Cayman) Inc financials in yearly and quarterly reports right on TradingView.
Wuxi Biologics (Cayman) Inc is going to release the next earnings report on Mar 24, 2026. Keep track of upcoming events with our Earnings Calendar.
WXIBF earnings for the last half-year are 0.08 USD per share, whereas the estimation was 0.06 USD, resulting in a 22.22% surprise. The estimated earnings for the next half-year are 0.09 USD per share. See more details about Wuxi Biologics (Cayman) Inc earnings.
Wuxi Biologics (Cayman) Inc revenue for the last half-year amounts to 1.39 B USD, despite the estimated figure of 1.36 B USD. In the next half-year revenue is expected to reach 1.69 B USD.
WXIBF net income for the last half-year is 320.00 M USD, while the previous report showed 259.23 M USD of net income which accounts for 23.44% change. Track more Wuxi Biologics (Cayman) Inc financial stats to get the full picture.
No, WXIBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 12.57 K employees. See our rating of the largest employees — is Wuxi Biologics (Cayman) Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Wuxi Biologics (Cayman) Inc EBITDA is 992.58 M USD, and current EBITDA margin is 33.44%. See more stats in Wuxi Biologics (Cayman) Inc financial statements.
Like other stocks, WXIBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Wuxi Biologics (Cayman) Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Wuxi Biologics (Cayman) Inc technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Wuxi Biologics (Cayman) Inc stock shows the buy signal. See more of Wuxi Biologics (Cayman) Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.